Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUPREME: A 12-Week, Open-Label, Multicenter Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia

NCT00465088 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00465088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00465088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUPREME: A 12-Week, Open-Label, Multicenter Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2007
Completion date
Not reported
Enrollment
199 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia, mixed dyslipidemia